Skip to main content
The American Journal of Case Reports logoLink to The American Journal of Case Reports
. 2022 Aug 28;23:e936402-1–e936402-5. doi: 10.12659/AJCR.936402

Intravascular Papillary Endothelial Hyperplasia (Masson’s Tumor) of the Supraclavicular Region: Management of a Rare Case

Eva Aurora Massimilla 1,A,D,E,F,, Gabriella Panetti 1,B,E,F, Giovanni Motta 1,B, Alfonso Fiorelli 2,B, Marco Montella 3,B,D, Domenico Testa 1,A,D, Gaetano Motta 1,A,D
PMCID: PMC9438939  PMID: 36030377

Abstract

Patient: Female, 24-year-old

Final Diagnosis: Hemangioendothelioma

Symptoms: Swelling

Medication: —

Clinical Procedure: —

Specialty: Otolaryngology • Surgery

Objective:

Rare disease

Background:

Masson’s tumor, also known as IPEH (intravascular papillary endothelial hyperplasia), is a rare benign vascular process, comprising approximately 2% of vascular tumors of the skin and subcutaneous tissue. IPEH presenting as a neck mass is rare, with only 5 reports of anterior neck mass and 7 cases of lateral neck lesions, of which 1 was in an external jugular vein aneurysm. To the best of our knowledge, the localization of intravascular papillary endothelial hyperplasia in the supraclavicular region is rarely reported.

Case Report:

We describe our management of a non-traumatic and non-painful mass on the right supraclavicular region in 24-year-old woman. Ultrasound revealed a heterogeneously hypoechoic mass with intense vascularization. Magnetic resonance imaging (MRI) showed a formation with lobulated contours and closely related to muscular layers of serratus anterior muscle. The findings of ultrasound-guided biopsy (FNA) were inconclusive. Complete removal of the mass was performed. Histopathological examination showed a well-circumscribed lesion with numerous small papillary structures. The papillae had hyalinized hypocellular cores covered by flattened endothelium. Immunohistochemical analysis showed endothelial positivity for CD34 and CD31. These features are typical of IPEH. No recurrence had occurred at 12 months after surgery.

Conclusions:

The differential diagnosis of malignant tumors like angiosarcoma is important because the prognosis significantly differs. Surgical excision is the treatment of choice. In our experience, the size of the lesion and its critical landmarks have not influenced the outcomes of the surgical procedure in terms of potential functional damages.

Keywords: Vascular Neoplasms; Head and Neck Neoplasms; Subcutaneous Tissue; Neck; Antigens, CD34; Vascular Diseases

Background

Intravascular papillary endothelial hyperplasia (IPEH) is a rare vascular lesion comprising approximately 2% of benign and malignant vascular tumors of skin and subcutaneous tissues [14]. It can occur in all age groups and has no race or ethnic group preferences [5] but there is a slight female predominance, which can be related to involvement of hormonal factors [6]. It can affect any blood vessel in the body but has a predilection for the head and neck region, fingers, trunk, and upper and lower extremities [7]. Most reported head and neck cases have involved skin and subcutaneous tissues of face and scalp [810]; less common sites are buccal mucosa [4,11], tongue [12,13], pharynx [14], larynx and hypopharynx [15], masseter muscle [16] and parotid gland [17], maxillary sinus [18], mandible [19], orbit [20], and ocular adnexa [21]. IPEH presenting as a neck mass is rare, with only 5 reports of anterior neck mass [2225] and 7 cases of lateral neck lesions [2632], of which 1 was in an external jugular vein aneurysm [30].

To the best of our knowledge, the localization of intravascular papillary endothelial hyperplasia in the supraclavicular region has rarely been reported [33,34]. Only 1 case in close proximity of serratus anterior muscular fibers was reported in the English language literature and treated by a multidisciplinary team.

Here, we report a clinical case of IPEH located in subcutaneous soft tissue of the supraclavicular region that was successfully managed by otolaryngologists without postoperative complications and with no recurrence of the disease 12 months after the surgical procedure.

Case report

A 24-year-old woman presented with non-traumatic and non-painful swelling on the right supraclavicular region that was noticed 1 year ago and was progressively increasing in size. At the dermatological examination, the lesion appeared mobile, non-tender, non-compressible, with fibroelastic consistency, without alterations of the overlying skin and pulsatility. Ultrasound revealed a heterogeneously hypoechoic mass and Doppler US recognized in it an intense vascularization.

T1-weighted and T2-weighted magnetic resonance imaging (MRI) was conducted, showing a 43×30×49 mm formation with lobulated contours and closely related to muscular layers of serratus anterior muscle (Figure 1A, 1B). The signal is mostly fluid (likely serohematic content) and few calcifications are described. After intravenous administration of contrast (gadobutrol) there is a septal enhancement.

Figure 1.

Figure 1.

(A) Coronal T2 HR FSE Propeller; (B) axial T2 STIR. A 43×30×49 mm formation with lobulated contours is closely related to muscular layers (circles). The signal is mostly fluid (likely serohematic contents) and few calcifications are present.

An ultrasound-guided biopsy was performed, but the findings were inconclusive.

The presence of a lymphangioma was hypothesized and the mass was radically excised for histopathological evaluation.

Intraoperative neurophysiologic monitoring has been used. The mass was completely removed. Macroscopically, the mass was 5.5×3×3.5 cm in size (Figures 2, 3). After surgery, a drainage tube has been placed. The patient had a fast and uncomplicated recovery. There was no evidence of recurrence after 12 months.

Figure 2.

Figure 2.

Surgical field. Small skin incision; a mass in the left supraclavicular fossa can be seen.

Figure 3.

Figure 3.

Resection “en-bloc” of the mass. Macroscopically, the mass was 5.5×3×3.5 cm in size.

Under pathologic examination, the lesion appears well-circumscribed and presents numerous small papillary structures. The papillae have a hyalinized hypocellular cores covered by flattened endothelium (Figure 4). Immunohistochemical analysis showed endothelial positivity for CD34 and CD31 (Figure 5). These features are typical of IPEH.

Figure 4.

Figure 4.

(A) Vascular malformation containing organizing thrombus with papillary endothelial hyperplasia (H&E, 2.5× magnification, scale bar 1mm). (B) Papillae with hyalinized hypocellular cores covered by flattened endothelium (black arrow-head) (H&E, 20× magnification, scale bar 100 µm).

Figure 5.

Figure 5.

Immunohistochemical analysis showed endothelial positivity for CD34 (A: 20× magnification, scale bar 100 µm) and CD31 (B: 10× magnification, scale bar 200 µm).

Discussion

The complexity of the anatomy of the supraclavicular fossa allows for an extensive differential diagnosis for regional pathology, which categorizes into neoplastic, congenital, and infectious etiologies. According to some authors, the majority of supraclavicular masses biopsied via FNA were found to be the result of a malignant process, with metastatic spread being far more likely than lymphoma [35,36].

IPEH was first described in 1923 by Pierre Masson [37]. He described an intravascular papillary proliferation in the lumen of an inflamed hemorrhoidal plexus in a 68-yarr-old man and named it “hémangioendothéliome végétant intravasculaire”.

In 1932, Folke Henschen [38] reported a similar case and named it “endovasculite proliférante thrombopoiétique”, describing it as a reactive process instead of a neoplasm. The name of “intravascular papillary endothelial hyperplasia” (IPEH), reported by Clearkin and Enzinger in 1976 [39], is currently the most commonly used, since it underlines the non-neoplastic character of this disease.

Three types of IPEH were described: a primary type, the most common, which is a pure endovascular form that originates in dilated vascular spaces; a mixed or secondary form that occurs in pre-existing vascular abnormalities; and the undetermined type, which is a rare extravascular hemangioma form that arises from hematomas [25,29]. The pathogenesis of IPEH seems to be multifactorial [10]. In 30% of cases, it is related to trauma or vascular abnormalities (eg, hemangiomas, vascular malformations, pyogenic granulomas, blood stasis) that induce a perivascular inflammation and favor the onset of a reactive process by endothelial cells through a consistent secretion of FGF-β [5]. However, the trigger stimulus is still not clear, so the etiology remains unknown [5,15,40]. Salyer et al found a peculiar pattern of thrombus organization [28,41]. CD 31 and CD 34 were found to be the most efficient immunohistological markers to identify the vascular origin of IPEH, in comparison to FVIII, type IV collagen, SMA and MSA antibodies, CD105, and Ki-67 [28,42]. Clinical and radiological features are not adequate to guide the diagnosis; therefore, histological characterization of the lesion is necessary.

IPEH can be mistaken for other benign subcutaneous tumors, such as lipomas, angiomas, and cysts, but the differential diagnosis is more important with malignant tumors like angiosarcoma and Kaposi’s sarcoma [7], since the prognosis will change.

Angiosarcoma is distinguished from Masson’s tumor by the presence at histopathological examination of solid and necrotic areas, mitotic figures, or pleomorphic cells and by the absence of confined intralaminar location [10,26]. Other differential diagnoses to consider are pyogenic granuloma, mucocele, the intravascular form of hemangioma, and malignant endovascular papillary angioendothelioma [25,29].

Surgical excision is the treatment of choice, generally with a good prognosis. Recurrences are rare and mostly associated with incomplete excision [25,26].

The size in combination with the site of the lesion gave us some concerns in terms of potential complications, due to the uncertain histology and vascularization of the mass.

Intraoperative neurophysiologic monitoring is crucial since several nerve structures such as the brachial plexus, cervical plexus, and phrenic nerve are potentially at risk.

Bleeding control has a fundamental role too, since IPEH has a conspicuous vascularization and the vasculature within the region of the supraclavicular triangle is complex, with presence of major vessels like subclavian, transverse cervical, and suprascapular arteries and veins, as well as external and internal jugular veins and their branches.

Conclusions

To the best of our knowledge, the localization of intravascular papillary endothelial hyperplasia in the supraclavicular region is rarely reported. The differential diagnosis with malignant tumors like angiosarcoma is fundamental since the subsequent prognosis will significantly change. Surgical excision is the treatment of choice. In our experience, the size of the lesion and its critical landmarks do not influence the outcomes of the surgical procedure in terms of potential functional damages.

Footnotes

Declaration of Figures’ Authenticity

All figures submitted have been created by the authors who confirm that the images are original with no duplication and have not been previously published in whole or in part.

References:

  • 1.Sasso SE, Naspolini AP, Milanez TB, Suchard G. Masson’s tumor (intravascular papillary endothelial hyperplasia) An Bras Dermatol. 2019;94(5):620–21. doi: 10.1016/j.abd.2019.09.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Almarghoub MA, Shah Mardan QNM, Alotaibi AS, et al. Masson’s tumor involving the hand: A case report. Int J Surg Case Rep. 2020;70:223–26. doi: 10.1016/j.ijscr.2020.04.069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Carta F, Sionis S, Ledda V, et al. Parotid Masson’s tumor: Case report. Braz J Otorhinolaryngol. 2018;84(4):523–25. doi: 10.1016/j.bjorl.2016.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Tosios K, Koutlas IG, Papanikolaou SI. Intravascular papillary hyperplasia of the oral soft tissues: Report of 18 cases and review of the literature. J Oral Maxillofacial Surg. 1994;52:1263–68. doi: 10.1016/0278-2391(94)90048-5. [DOI] [PubMed] [Google Scholar]
  • 5.Cagli S, Oktar N, Dalbasti T, et al. Intravascular papillary endothelial hyper-plasia of the central nervous system – four case reports. Neurol Med Chir (Tokyo) 2004;44:302–10. doi: 10.2176/nmc.44.302. [DOI] [PubMed] [Google Scholar]
  • 6.Pins MR, Rosenthal DI, Springfield DS, Rosenberg AE. Florid extravascular papillary endothelial hyperplasia (Masson’s pseudoangiosarcoma) presenting as a soft-tissue sarcoma. Arch Pathol Lab Med. 1993;117:259–63. [PubMed] [Google Scholar]
  • 7.Hong SG, Cho HM, Chin HM, et al. Intravascular papillary endothelial hyper-plasia (Masson’s hemangioma) of the liver: A new hepatic lesion. J Korean Med Sci. 2004;19(2):305–8. doi: 10.3346/jkms.2004.19.2.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Amerigo J, Matilla A, Gonzalez-Campora R, Galera-Davidson H. Vegetant intravascular hemangioendothelioma of the skin. Report of 3 cases with a critical pathogenetic study. Dermatologica. 1979;159:476–81. [PubMed] [Google Scholar]
  • 9.Cozzutto C, Guarino M, Dodera P, Nattera G. Intravascular endothelial praliferations in children. Am J Clin Pathol. 1979;71:247–52. doi: 10.1093/ajcp/71.3.247. [DOI] [PubMed] [Google Scholar]
  • 10.Luce EB, Montgomery MT, Redding SW, Aufdemorte TB. Intravascular angiomatosis (Masson’s lesion) J Oral Maxillofac Surg. 1988;46:736–41. doi: 10.1016/0278-2391(88)90182-6. [DOI] [PubMed] [Google Scholar]
  • 11.Bodner L, Dayan D. Intravascular papillary endothelial hyperplasia of the mandibular mucosa. Int J Oral Maxillofac Surg. 1991;20:273–74. doi: 10.1016/s0901-5027(05)80152-3. [DOI] [PubMed] [Google Scholar]
  • 12.Torne Escasany R, Umbert Millet P. Masson’s pseudoangiosarcoma of the tongue: Report of two cases. J Cutan Pathol. 1985;12:66–71. doi: 10.1111/j.1600-0560.1985.tb00431.x. [DOI] [PubMed] [Google Scholar]
  • 13.Stern Y, Braslavsky D, Shpitzcr T, Feinmesser R. Papillary endothelial hyper-plasia in the tongue: A benign lesion that may be mistaken for angiosarcoma. J Otolaryngol. 1994;23:81–83. [PubMed] [Google Scholar]
  • 14.Ejeckam GC, Orizaga M, Gerin-Lajoie J, Castilio G. Intravascular angiomatosis of the pharynx (Masson’s vegetant intravascular haemangioendothelioma) – a case report. Br J Oral Surg. 1978;16:105–10. doi: 10.1016/0007-117x(78)90019-7. [DOI] [PubMed] [Google Scholar]
  • 15.Tedla M, Bežová M, Biró C, et al. Intravascular papillary endothelial hyper-plasia of larynx: Case report and literature review of all head and neck cases. Otolaryngol Pol. 2014;68(4):200–3. doi: 10.1016/j.otpol.2014.03.002. [DOI] [PubMed] [Google Scholar]
  • 16.Rodriguez Campo FJ, Monje Gil F, Chayes Benito A, et al. [Intravascular endothelial papillary hyperplasia in the masseter muscle] Rev Stomatol Chir Maxillofac. 1991;92:420–24. [PubMed] [Google Scholar]
  • 17.Corio RL, Brannon RB, Tarpley TM. Intravascular papillary endothelial hyperplasia of the head and neck. Ear Nose Thraat J. 1982;61:88–91. [Google Scholar]
  • 18.Lancaster JL, Alderson DJ, Sherman IW, Clark AH. Papillary endothelial hyperplasia (Masson’s tumour) of the maxillary sinus. J Larnyngol Oto. 1998;112:500–2. doi: 10.1017/s0022215100140903. [DOI] [PubMed] [Google Scholar]
  • 19.Komori A, Koike M, Kinjo T, et al. Central intravascular papillary endothelial hyperplasia of the mandible. Virchows Arch A Pathol Anat Histopathol. 1984;403:453–59. doi: 10.1007/BF00737293. [DOI] [PubMed] [Google Scholar]
  • 20.Weber FL, Babel J. Intravascular papillary endothelial hyperplasia of the orbit. Br J OphlhalmoI. 1981;65:18–22. doi: 10.1136/bjo.65.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Werner MS, Hornblass A, Reifler DM, et al. Intravascular papillary endothelial hyperplasia: Collection of four cases and a review of the literature. Ophthal Plast Reconstr Surg. 1997;13:48–56. [PubMed] [Google Scholar]
  • 22.Pye JK. A case of Masson’s vegetant, intravascular haemangio-endotheliorna presenting in a large neck vein. Clin Oncol. 1983;9:57–59. [PubMed] [Google Scholar]
  • 23.Youngerman JS. Intravascular papillary endothelial hyperplasia. Arch Otolaryngol. 1984;110:274–75. : 277. [PubMed] [Google Scholar]
  • 24.Chen KT. Extravascular papillary endothelial hyperplasia. J Surg Oncol. 1987;36:52–54. doi: 10.1002/jso.2930360112. [DOI] [PubMed] [Google Scholar]
  • 25.Hashimoto H, Daimaru Y, Enjoji M. Intravascular papillary endothelial hyperplasia. A clinicopathologic study of 91 cases. Am J Derrnat opathol. 1983;5:539–46. doi: 10.1097/00000372-198312000-00004. [DOI] [PubMed] [Google Scholar]
  • 26.Pantanowitz L, Muc R, Spanger M, et al. Intravascular papillary endothelial hyperplasia (Masson’s tumor) manifesting as a lateral neck mass. Ear Nose Throat J. 2000;79(10):806. [809–10, 812 passim] [PubMed] [Google Scholar]
  • 27.Yücesoy C, Coban G, Yilmazer D, et al. Intravascular papillary endothelial hyperplasia (Masson’s hemangioma) presenting as a lateral neck mass. JBR-BTR. 2009;92(1):20–22. [PubMed] [Google Scholar]
  • 28.Alotaibi M, Geisler V, Olze H, Knopke S. Masson tumor as a neck mass. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137(3):217–18. doi: 10.1016/j.anorl.2018.11.010. [DOI] [PubMed] [Google Scholar]
  • 29.da Silva Leal M, Amado C, Paracana B, et al. Masson’s tumour: A rare cause of cervical mass. Eur J Case Rep Intern Med. 2021;8(12):003078. doi: 10.12890/2021_003078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.El Husseiny M, Benhaiem N, Vayssairat M, Allaire E. Masson’s vegetant intravascular hemangioendothelioma in an external jugular vein aneurysm with recurrent thrombosis. J Vasc Surg. 2011;53(6):1723–25. doi: 10.1016/j.jvs.2011.01.059. [DOI] [PubMed] [Google Scholar]
  • 31.Suh KS, Shin KS, Park IA. Intravascular papillary endothelial hyperplasia of the neck masquerading as malignancy on fine-needle aspiration cytology. Diagn Cytopathol. 2003;29(1):14–17. doi: 10.1002/dc.10207. [DOI] [PubMed] [Google Scholar]
  • 32.Nangia A, Sehgal S, Agarwal K. Masson’s tumor masquerading as a papillary adenocarcinoma on fine needle aspiration cytology: A case report. Turk Patoloji Derg. 2018;34(2):179–81. doi: 10.5146/tjpath.2015.01334. [DOI] [PubMed] [Google Scholar]
  • 33.Shenton C, Sarwar S, Goswamy J. Cervicothoracic ‘no man’s land’: An unusual location of intravascular papillary endothelial hyperplasia in the supraclavicular fossa presenting a surgical challenge. BMJ Case Rep. 2021;14:e240479. doi: 10.1136/bcr-2020-240479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gutiérrez Sánchez AM, Calabuig Adobes A, Carmen Marcén G, et al. Hiperplasia endotelial papilar intravascular en la región supraclavicular. Rev Pediatr Aten Primaria. 2021;23:87–90. [Google Scholar]
  • 35.Franzen A, Günzel T, Buchali A, Coordes A. Etiologic and differential diagnostic significance of tumor location in the supraclavicular fossa. Laryngoscope. 2018;128(3):646–50. doi: 10.1002/lary.26775. [DOI] [PubMed] [Google Scholar]
  • 36.Ellison E, LaPuerta P, Martin SE. Supraclavicular masses: Results of a series of 309 cases biopsied by fine needle aspiration. Head Neck. 1999;21(3):239–46. doi: 10.1002/(sici)1097-0347(199905)21:3<239::aid-hed9>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  • 37.Masson P. [Intravascular vegetative hemangioendothelioma.] Bull Mem Soc Anat. 1923;93:517–23. [in French] [Google Scholar]
  • 38.Henschen P. [Thrombopoietin proliferative endovasculitis in local vascular lesion.] Ann Anat Pathol. 1932;9:113–21. [Google Scholar]
  • 39.Clearkin KP, Enzinger FM. Intravascular papillary endothelial hyperplasia. ArchPathol Lab Med. 1976;100(8):441–44. [PubMed] [Google Scholar]
  • 40.Giannitto C, Mercante G, Spriano G, et al. CT and MRI findings of head and neck Masson’s tumor: A rare case report and systematic review of the literature. Rep Med Imaging. 2021;14:53–64. [Google Scholar]
  • 41.Salyer WR, Salyer DC. Intravascular angiomatosis: Development and distinctionfrom angiosarcoma. Cancer. 1975;36(3):995–1001. doi: 10.1002/1097-0142(197509)36:3<995::aid-cncr2820360323>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  • 42.Akdur NC, Donmez M, Gozel S, et al. Intravascular papillary endothelial hyperplasia: Histomorphological and immunohistochemical features. Diagn Pathol. 2013;8(1):167. doi: 10.1186/1746-1596-8-167. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Case Reports are provided here courtesy of International Scientific Information, Inc.

RESOURCES